On-body delivery systems incorporate small portable batteries to administer medication subcutaneously. End-user removability of such batteries could result in improper functioning of the device and in a false administration of medication, which could be a safety risk for the user.
Recital 7, Regulation (EU) 2026/1770
In forcesince 14 Jul 2026